These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1326 related items for PubMed ID: 15639698

  • 1. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR, Berson DS, Thiboutot DM, Leyden JJ, Parizadeh D, Sefton J, Walker PS, Gibson JR, Tazarotene Cream in Acne Clinical Study Investigator Group.
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [Abstract] [Full Text] [Related]

  • 2. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R, Rizer R, Barba A, Wilson D, Stewart D, Grossman R, Nighland M, Weiss J.
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [Abstract] [Full Text] [Related]

  • 3. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
    Leyden J, Thiboutot DM, Shalita AR, Webster G, Washenik K, Strober BE, Shupack J.
    Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
    [Abstract] [Full Text] [Related]

  • 4. The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.
    Feldman SR, Werner CP, Alió Saenz AB.
    J Drugs Dermatol; 2013 Apr; 12(4):438-46. PubMed ID: 23652892
    [Abstract] [Full Text] [Related]

  • 5. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
    Tanghetti E, Dhawan S, Green L, Ling M, Downie J, Germain MA, Kasteler JS, Kircik L, Oefelein MG, Draelos Z.
    J Drugs Dermatol; 2011 Jul; 10(7):783-92. PubMed ID: 21720661
    [Abstract] [Full Text] [Related]

  • 6. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E, Dhawan S, Torok H, Kircik L.
    Dermatol Online J; 2007 Jul 13; 13(3):1. PubMed ID: 18328195
    [Abstract] [Full Text] [Related]

  • 7. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
    Leyden JJ, Shalita A, Thiboutot D, Washenik K, Webster G.
    Clin Ther; 2005 Feb 13; 27(2):216-24. PubMed ID: 15811485
    [Abstract] [Full Text] [Related]

  • 8. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
    Leyden JJ, Tanghetti EA, Miller B, Ung M, Berson D, Lee J.
    Cutis; 2002 Feb 13; 69(2 Suppl):12-9. PubMed ID: 12095064
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
    Thiboutot D, Arsonnaud S, Soto P.
    J Drugs Dermatol; 2008 Jun 13; 7(6 Suppl):s3-10. PubMed ID: 18575220
    [Abstract] [Full Text] [Related]

  • 10. Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.
    Leyden JJ.
    Cutis; 2004 Oct 13; 74(4 Suppl):9-15. PubMed ID: 15543714
    [Abstract] [Full Text] [Related]

  • 11. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
    Tanghetti E, Abramovits W, Solomon B, Loven K, Shalita A.
    J Drugs Dermatol; 2006 Mar 13; 5(3):256-61. PubMed ID: 16573259
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
    Webster GF, Guenther L, Poulin YP, Solomon BA, Loven K, Lee J.
    Cutis; 2002 Feb 13; 69(2 Suppl):4-11. PubMed ID: 12095066
    [Abstract] [Full Text] [Related]

  • 13. Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
    Shalita A, Miller B, Menter A, Abramovits W, Loven K, Kakita L.
    J Drugs Dermatol; 2005 Feb 13; 4(2):153-8. PubMed ID: 15776771
    [Abstract] [Full Text] [Related]

  • 14. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
    Pariser D, Colón LE, Johnson LA, Gottschalk RW.
    J Drugs Dermatol; 2008 Jun 13; 7(6 Suppl):s18-23. PubMed ID: 18575222
    [Abstract] [Full Text] [Related]

  • 15. Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study.
    Shalita AR, Chalker DK, Griffith RF, Herbert AA, Hickman JG, Maloney JM, Miller BH, Tschen EH, Chandraratna RA, Gibson JR, Lew-Kaya DA, Lue JC, Sefton J.
    Cutis; 1999 Jun 13; 63(6):349-54. PubMed ID: 10388959
    [Abstract] [Full Text] [Related]

  • 16. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
    Gold LS, Colón LE, Johnson LA, Gottschalk RW.
    J Drugs Dermatol; 2008 Jun 13; 7(6 Suppl):s11-7. PubMed ID: 18575221
    [Abstract] [Full Text] [Related]

  • 17. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.
    Grimes P, Callender V.
    Cutis; 2006 Jan 13; 77(1):45-50. PubMed ID: 16475496
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF, Alió Sáenz AB.
    J Drugs Dermatol; 2011 Dec 13; 10(12):1382-96. PubMed ID: 22134562
    [Abstract] [Full Text] [Related]

  • 19. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
    Tanghetti E, Dhawan S, Green L, Del Rosso J, Draelos Z, Leyden J, Shalita A, Glaser DA, Grimes P, Webster G, Barnett P, Le Gall N.
    J Drugs Dermatol; 2010 May 13; 9(5):549-58. PubMed ID: 20480800
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P, Boorman GC, Donald AE, Davies HD.
    J Dermatolog Treat; 2002 Sep 13; 13(3):111-7. PubMed ID: 12227873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.